Pericardial patch venoplasty heals via attraction of venous progenitor cells

Physiol Rep. 2016 Jun;4(12):e12841. doi: 10.14814/phy2.12841.

Abstract

Pericardial patches are commonly used during cardiovascular surgery to close blood vessels. In arteries, patches accumulate arterial progenitor cells; we hypothesized that venous patches would accumulate venous progenitor cells, in the absence of arterial pressure. We developed a novel rat inferior vena cava (IVC) venotomy model and repaired it with a pericardial patch. Cells infiltrated the patch to form a thick neointima by day 7; some cells were CD34(+)/VEGFR2(+) and CD31(+)/Eph-B4(+) consistent with development of venous identity in the healing patch. Compared to arterial patches, the venous patches had increased neointimal thickness at day 7 without any pseudoaneurysms. Addition of an arteriovenous fistula (AVF) to increase blood flow on the patch resulted in reduced patch neointimal thickness and proliferation, but neointimal thickness was not reversible with AVF ligation. These results show that rat patch venoplasty is a novel model of aggressive venous neointimal hyperplasia.

Keywords: AVF ligation; Aortocaval fistula; Eph‐B4; arterioplasty; arteriovenous fistula; pericardial patches; pseudoaneurysm; venoplasty; venous neointimal hyperplasia.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult Stem Cells / cytology*
  • Adult Stem Cells / metabolism
  • Angioplasty / adverse effects
  • Angioplasty / methods*
  • Animals
  • Antigens, CD34 / metabolism
  • Male
  • Pericardium / surgery*
  • Platelet Endothelial Cell Adhesion Molecule-1 / metabolism
  • Rats
  • Rats, Wistar
  • Receptor, EphB4 / metabolism
  • Regeneration*
  • Tunica Intima / cytology
  • Tunica Intima / metabolism
  • Vascular Closure Devices / adverse effects
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism
  • Vena Cava, Inferior / physiology
  • Vena Cava, Inferior / surgery*

Substances

  • Antigens, CD34
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Receptor, EphB4
  • Vascular Endothelial Growth Factor Receptor-2